Case Comprehensive Cancer Center: clinical-trial pipeline
Case Comprehensive Cancer Center is the sponsor of 493 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 71 are not yet finished and 2 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 244 |
| Phase 2 | 131 |
| Phase 1 | 63 |
| Early phase 1 | 26 |
| Phase 1/2 | 15 |
| Phase 3 | 12 |
| Phase 4 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 270 |
| Withdrawn or not authorised | 78 |
| Terminated | 68 |
| Recruiting | 46 |
| Not yet recruiting | 13 |
| Active, not recruiting | 12 |
| Suspended or halted | 5 |
| Unknown | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 446 |
| Nephrology and urology | 76 |
| Gastroenterology and liver | 43 |
| Rare and genetic diseases | 27 |
| Women's health and obstetrics | 22 |
| Haematology | 15 |
| Psychiatry and mental health | 14 |
| Dermatology | 13 |
| Infectious disease and vaccines | 10 |
| Metabolic and endocrine (diabetes, obesity) | 10 |
| Musculoskeletal | 9 |
| Neurology | 9 |
Countries
| Country | Trials |
|---|---|
| United States | 453 |
| Kenya | 1 |
| Uganda | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-15 | New trial posted | Feasibility and Effectiveness of Sentinel Lymph Node Biopsy in Inflammatory Breast Cancer |
| 2026-09-22 | New trial posted | High-concentration Capsaicin Patch for the Prevention of Paclitaxel-induced Peripheral Ne… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05590624 | Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer | Not applicable | Recruiting | United States |
| NCT04362826 | Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer | Not applicable | Recruiting | United States |
| NCT07104630 | Pulmonary Rehabilitation in Advanced Lung Cancer Survivors | Phase 2 | Recruiting | United States |
| NCT05825482 | Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® | Not applicable | Active, not recruiting | United States |
| NCT06421155 | Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia | Not applicable | Recruiting | United States |
| NCT01843413 | Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases | Phase 1 | Active, not recruiting | United States |
| NCT06357845 | Linking Somatic Mutation Rate With Baseline Exposure in East Palestine | Not applicable | Recruiting | United States |
| NCT06150417 | MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) | Phase 2 | Recruiting | United States |
| NCT07129226 | Musculoskeletal Cancers Remote Monitoring and Care | Not applicable | Recruiting | United States |
| NCT07003542 | A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas | Phase 2 | Recruiting | United States |
| NCT05020912 | Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy | Phase 2 | Active, not recruiting | United States |
| NCT06738303 | Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer | Phase 2 | Recruiting | United States |
| NCT06811454 | Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) | Not applicable | Not yet recruiting | United States |
| NCT06263088 | EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients Wit… | Not applicable | Recruiting | United States |
| NCT06101069 | Development of MRF for Characterization of Brain Tumors After Radiotherapy | Not applicable | Recruiting | United States |
| NCT07524634 | Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain… | Phase 2 | Not yet recruiting | United States |
| NCT04545177 | Improving Understanding of Brain Tumors Through Preservation of Biologically Active Brain Tissue | Not applicable | Active, not recruiting | United States |
| NCT04218617 | Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases | Phase 2 | Recruiting | United States |
| NCT07541365 | Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials | Not applicable | Recruiting | United States |
| NCT06926530 | Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations | Not applicable | Not yet recruiting | United States |
| NCT02802553 | Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions | Not applicable | Active, not recruiting | United States |
| NCT05209074 | Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma | Phase 1 | Active, not recruiting | United States |
| NCT05970107 | Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients | Not applicable | Not yet recruiting | |
| NCT06649201 | Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation | Not applicable | Recruiting | United States |
| NCT07219745 | Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS) | Not applicable | Not yet recruiting | United States |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Case Comprehensive Cancer Center clinical trials: 71 open, 12 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/case-comprehensive-cancer-center/, data as of 2026-10-25.